ZyVersa Therapeutics Inc (ZVSA)
0.7899
-0.01
(-1.39%)
USD |
NASDAQ |
Mar 14, 16:00
0.7625
-0.03
(-3.47%)
After-Hours: 20:00
ZyVersa Therapeutics Price to Book Value: 0.2635 for March 14, 2025
View 4,000+ Financial Data Types:
Add
Browse
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Omeros Corp | -- |
| Chimerix Inc | 5.604 |
| BioXcel Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.888 |
| Palatin Technologies Inc | -- |
Price to Book Value Related Metrics
| Price | 0.7899 |
| Earnings Yield | -14.40K% |
| Market Cap | 1.852M |